The authors are the principal investigators of the British Society of Rheumatology (BSR) Biologics Register. The BSR receives financial support for the Register from the manufacturers of biologic agents currently licensed for use in the treatment of patients with inflammatory rheumatic diseases. The
Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis
โ Scribed by Karin Hellgren; Karin E. Smedby; Nils Feltelius; Eva Baecklund; Johan Askling
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 92 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective Patients with rheumatoid arthritis (RA) are at increased risk for malignant lymphomas. Both conditions display a familial aggregation, and there are reports of RA and malignant lymphomas occurring in the same families. This study was undertaken to determine the risk of mal
## Abstract ## Objective To explore the contribution of female hormonal factors occurring prior to the onset of rheumatoid arthritis (RA), such as age at menarche, parity, age at first birth, breastโfeeding, use of oral contraceptives (OCs), irregular menstrual cycles, and postmenopausal hormone (
## Abstract ## Objective The shared epitope (SE)โcontaining HLAโDRB1 alleles represent the most significant genetic risk factor for rheumatoid arthritis (RA). Recent studies indicate that the SE alleles are associated with only RA that is characterized by the presence of antiโcyclic citrullinated